The current valuation score of Journey Medical Corp is 9.15, ranking 30 out of 158 in the Pharmaceuticals industry. Its current P/E ratio is -20.34, which is -328.23% below the recent high of 46.43 and -71.11% above the recent low of -34.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.